PIAS4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.135600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.406600E-01
Normal-vs-Stage2
9.173400E-01
Normal-vs-Stage3
2.959200E-01
Normal-vs-Stage4
5.870200E-01
Stage1-vs-Stage2
8.321600E-02
Stage1-vs-Stage3
1.106410E-01
Stage1-vs-Stage4
6.678200E-01
Stage2-vs-Stage3
1.477430E-01
Stage2-vs-Stage4
4.435000E-01
Stage3-vs-Stage4
1.665030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.293800E-01
Normal-vs-AfricanAmerican
5.757600E-01
Normal-vs-Asian
7.237200E-01
Caucasian-vs-AfricanAmerican
7.241200E-01
Caucasian-vs-Asian
6.254200E-01
AfricanAmerican-vs-Asian
9.876800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.414000E-01
Normal-vs-Female
8.956600E-01
Male-vs-Female
7.296600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.039200E-01
Normal-vs-Age(41-60Yrs)
7.630000E-01
Normal-vs-Age(61-80Yrs)
9.824000E-01
Normal-vs-Age(81-100Yrs)
8.182200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.942600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.182400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.772600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.961000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.567000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.811200E-01
Normal-vs-Daily Drinker
9.885400E-01
Normal-vs-Weekly Drinker
9.691800E-01
Normal-vs-Occasional Drinker
7.165400E-01
Normal-vs-Social Drinker
7.454800E-01
Non Drinker-vs-Daily Drinker
6.266400E-01
Non Drinker-vs-Weekly Drinker
5.725200E-01
Non Drinker-vs-Occasional Drinker
2.529800E-01
Non Drinker-vs-Social Drinker
3.153200E-01
Daily Drinker-vs-Weekly Drinker
9.294800E-01
Daily Drinker-vs-Occasional Drinker
4.116600E-01
Daily Drinker-vs-Social Drinker
4.711400E-01
Weekly Drinker-vs-Occasional Drinker
4.575400E-01
Weekly Drinker-vs-Social Drinker
5.613600E-01
Occasional Drinker-vs-Social Drinker
8.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.605600E-01
Normal-vs-Grade 2
3.073600E-02
Normal-vs-Grade 3
4.455000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.878600E-01
Grade 1-vs-Grade 3
3.729800E-01
Grade 1-vs-Grade 4
2.605600E-01
Grade 2-vs-Grade 3
6.372800E-01
Grade 2-vs-Grade 4
3.073600E-02
Grade 3-vs-Grade 4
4.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.661800E-01
Normal-vs-NonDiabetic
8.160400E-01
Diabetic-vs-NonDiabetic
8.370400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.623600E-01
Normal-vs-NoPancreatitis
9.346200E-01
Pancreatitis-vs-NoPancreatitis
8.200200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.462800E-01
Normal-vs-N1
8.980400E-01
N0-vs-N1
1.329220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.172400E-01
Normal-vs-TP53-NonMutant
3.543200E-01
TP53-Mutant-vs-TP53-NonMutant
5.159900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
